Role of sodium l-cysteine alginate conjugate and isopropyl myristate to enhance the permeation enhancing activity of BCS class III drug from TDDS; optimization by central composite design and <i>in vivo</i> pharmacokinetics study.

Sadashivaiah, R; Babu, B K Satheesha

Role of sodium l-cysteine alginate conjugate and isopropyl myristate to enhance the permeation enhancing activity of BCS class III drug from TDDS; optimization by central composite design and in vivo pharmacokinetics study.

Sadashivaiah, R; Babu, B K Satheesha.

Afiliação

Sadashivaiah R; Department of Pharmaceutics, Government College of Pharmacy, Bengaluru, India.
Babu BKS; Department of Pharmaceutics, Government College of Pharmacy, Bengaluru, India.

Drug Dev Ind Pharm ; 46(9): 1427-1442, 2020 Sep.

Article em En | MEDLINE | ID: mdl-32623912

Assuntos

Alginatos; Cisteína; Miristatos/química; Administração Cutânea; Animais; Sistemas de Liberação de Medicamentos; Permeabilidade; Coelhos; Sódio; Adesivo Transdérmico

Palavras-chave

Design expert; Parkinson's disease; liquid chromatographymass spectrometry; proton NMR; skin irritation studies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisteína / Alginatos / Miristatos Limite: Animals Idioma: En Revista: Drug Dev Ind Pharm Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google